Life Science Investing Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference
Life Science Investing Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference
Life Science Investing Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
Life Science Investing Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
Life Science Investing Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology Annual Meeting
Life Science Investing Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
NextSource Materials Executes Term Sheets with Strategic Investors and Local Capital Partners to Advance Towards Final Investment Decision for its Proposed UAE Battery Anode Facility
Kobo Delivers Significant Progress at its Kossou Gold Project in 2025, Establishes a Scalable West African Gold Platform for 2026 and Hosted the 2nd Annual Kobo Cup